Effects of cyclosporine on renal function in psoriasis patients - 12/10/17

Doi : 10.1016/0190-9622(90)70356-M

Joseph M. Messana, MD ^{^{a
From the Division of Nephrology, Department of Internal Medicine, University of Michigan Medical Center.},}^⁎, Leslie L. Rocher, MD ^{^{a
From the Division of Nephrology, Department of Internal Medicine, University of Michigan Medical Center.}}, Charles N. Ellis, MD ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, Mark S. Fradin, MD ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, John R. VanGurp, MD ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, Graciella Cantu-Gonzalez, MD ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, Thomas G. Parish, PA-C ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, Suzanne M. Wheeler, BS ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}, John J. Voorhees, MD ^{^{b
the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center.}}
Ann Arbor, Michigan, USA

^*Reprint requests: Joseph M. Messana, MD, 3914 Taubman Center, Box 0364, University of Michigan Medical Center, Ann Arbor, MI 48109-0314.

Abstract

Several prospective studies have documented the effectiveness of oral cyclosporine in the treatment of psoriasis. Despite this, the use of cyclosporine has heen limited because of concern about the possibility of drug-induced renal dysfunction. We review the effects of cyclosporine on renal function.

Le texte complet de cet article est disponible en PDF.